Melanotan II Dosage Guide: How Much, How Often, and Common Mistakes

Melanotan II at a glance:

• Drug class: Cosmetic peptide
• Route: topical for most; injectable melanotans are unlicensed
• Typical frequency: daily topical application typical
• Half-life: topical residence time varies

The wrong Melanotan II dose — too high, too low, or escalated too quickly — is the most common reason people stop the drug. Cosmetic peptides in skincare are regulated as cosmetics, not drugs.

Standard Dosing Schedule for Melanotan II

Cosmetic peptides in skincare are regulated as cosmetics, not drugs. Injectable melanotans are not FDA-approved.

The typical schedule for Melanotan II is daily topical application typical via topical for most; injectable melanotans are unlicensed. Half-life of topical residence time varies explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Melanotan II holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Melanotan II is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (topical residence time varies) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Melanotan II side effects and the cost angle of dose escalation in Melanotan II cost.

What the Trials Used

Published clinical data on this compound is limited. Most reported dosing comes from observational or non-clinical sources.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Melanotan II: the standard contraindications for this drug class apply.

Bottom Line

Most Melanotan II dose questions resolve in a 5-minute conversation with a clinician. Don't carry them around — get them answered.

Frequently Asked Questions

Related Reading

• Melanotan II Explained: How It Works and Who It's For
• Melanotan II Side Effects in 2026: Real Reports, Real Solutions
• Real Melanotan II Results: What 6 and 12 Months Actually Look Like
• Melanotan II Price Decoded: Insurance, Coupons, and Cash-Pay Options
• The Honest Guide to GHK-Cu: What Patients and Doctors Actually Say
• Melanotan II Cycle Guide: Published Research vs. Online Protocols

Sources

• Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. J Biomater Sci Polym Ed 2008;19:969.
• Habbema L et al. Risks of Unregulated Use of Alpha-Melanocyte-Stimulating Hormone Analogues. Br J Dermatol 2017;176:633.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.